SCHEMBL9683476

SCHEMBL9683476

CN(C)CCN1C2c3ccccc3C1c1sccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.36
HTR2A P28223 4/20 0.33
HRH1 P35367 3/20 0.33
HTR2C P28335 2/20 0.33
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 2/20 0.32
RET P07949 1/20 0.32
MEN1 O00255 1/20 0.31
ALOX15 P16050 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
SLC22A1 O15245 1/20 0.31
PRNP P04156 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
ADRB2 P07550 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
HTR1A P08908 1/20 0.31
CHRM5 P08912 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9684133 0.92 CYP2D6 (0.38) KDM1AHTR2AHRH1HTR2CALDH1A1
SCHEMBL9683338 0.86 POLB (0.34) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL9683453 0.80 OPRM1 (0.35) SLC6A2SLC6A4OPRM1
SCHEMBL9683465 0.79 CARM1 (0.33) HTR2AHRH1HTR2CKDM4EMEN1
SCHEMBL9684167 0.78 ALDH1A1 (0.31) ALDH1A1
SCHEMBL9684632 0.77 SLC6A2 (0.36) HTR2AHRH1HTR2CKDM4EMEN1
SCHEMBL9683517 0.75 HTT (0.30)
SCHEMBL9682581 0.74 HTT (0.35) KDM4ESLC6A2SLC6A4
SCHEMBL9684243 0.74 CHRM2 (0.37) ALDH1A1ALOX15KMT2ATP53CHRM2
SCHEMBL9684281 0.73 OPRM1 (0.37) OPRM1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0475187-A1 Naphthothiophenimines for treating neuronal disorders caused by ischemia BRISTOL-MYERS SQUIBB COMPANY (US) 1992-03-18 EP disclosed
US-5064831-A N-methyl-d-aspartate receptor antagonist BRISTOL-MYERS SQUIBB CO. (US) 1991-11-12 US disclosed